GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

JLK 322510.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

3,940

-1.50%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩3.34bn

FY2017FY2025

Net income

−₩13.61bn

FY2017FY2025

Free cash flow

−₩12.68bn

FY2017FY2025

Shareholders' equity

₩41.36bn

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₩3.34bn₩1.43bn₩2.49bn₩3.42bn₩3.79bn₩4.49bn₩229.5m₩362.9m₩84.1m
Research and development₩3.37bn₩2.74bn₩1.20bn₩2.94bn₩2.54bn₩2.47bn₩2.52bn——
Operating income—−₩12.74bn−₩6.57bn−₩8.95bn−₩7.33bn−₩7.53bn−₩10.79bn−₩4.62bn−₩2.53bn
Net income−₩13.61bn−₩13.45bn−₩7.32bn−₩9.01bn−₩7.57bn−₩7.64bn−₩10.64bn−₩6.28bn−₩8.41bn
Diluted earnings per share-540.16-533.94-462.45-600.76-510.76-517.33-729.47-570.66-1,682.16

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₩74.43bn₩74.59bn₩33.15bn₩36.33bn₩40.45bn₩46.55bn₩38.70bn₩9.42bn₩5.25bn
Cash and short-term investments—₩47.72bn₩6.11bn₩8.16bn₩10.86bn₩18.14bn₩35.82bn₩7.32bn₩3.78bn
Total liabilities₩33.07bn₩25.28bn₩21.43bn₩19.71bn₩16.36bn₩15.88bn₩2.40bn₩3.33bn₩13.90bn
Debt₩8.04bn₩22.11bn₩18.12bn₩16.53bn₩11.82bn₩11.87bn₩283.0m₩2.07bn₩2.90bn
Shareholders' equity₩41.36bn₩49.31bn₩11.73bn₩16.62bn₩24.08bn₩30.67bn₩36.30bn₩6.10bn−₩8.64bn
Shares outstanding25m25m16m15m15m15m15m11m5m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−₩12.34bn−₩10.94bn−₩6.38bn−₩7.90bn−₩6.10bn−₩4.12bn−₩6.42bn−₩3.82bn−₩3.21bn
Capital spending−₩334.7m−₩60.0m−₩364.4m−₩471.5m−₩1.45bn−₩17.45bn−₩288.7m−₩725.0m−₩1.20bn
Free cash flow−₩12.68bn−₩11.00bn−₩6.74bn−₩8.37bn−₩7.55bn−₩21.56bn−₩6.71bn−₩4.54bn−₩4.40bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩520.1m₩411.7m₩896.6m₩895.1m₩1.06bn₩484.7m₩813.0m₩250.1m
Operating income————−₩2.89bn−₩3.34bn−₩2.81bn−₩3.23bn
Net income−₩3.74bn−₩3.81bn−₩5.40bn−₩2.17bn−₩2.82bn−₩3.21bn−₩2.79bn−₩3.49bn
Diluted earnings per share-146.42-149.28-214.49-85.99-112.09-127.59-110.89-183.29
Cash from operations−₩1.94bn−₩3.80bn−₩4.47bn−₩2.48bn−₩2.26bn−₩3.13bn−₩10.94bn−₩7.43bn
Capital spending−₩35.0m−₩22.0m−₩13.0m−₩211.0m−₩28.0m−₩82.0m−₩60.0m−₩50.0m
Free cash flow−₩1.98bn−₩3.82bn−₩4.48bn−₩2.69bn−₩2.29bn−₩3.21bn−₩11.00bn−₩7.48bn
Total assets₩69.51bn₩72.29bn₩74.43bn₩80.17bn₩69.85bn₩71.88bn₩74.59bn₩29.72bn
Cash and short-term investments——————₩47.72bn₩3.02bn
Debt₩9.10bn₩8.57bn₩8.04bn₩5.99bn——₩15.04bn₩15.35bn
Shareholders' equity₩34.70bn₩38.41bn₩41.36bn₩46.99bn₩43.86bn₩46.47bn₩49.31bn₩2.94bn

Financial ratios

Data as of 5 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin—-892.5%-264.0%-261.9%-193.6%-167.8%-4702.5%
Net margin-407.4%-942.5%-294.2%-263.9%-200.1%-170.1%—
Return on equity-32.9%-27.3%-62.4%-54.2%-31.4%-24.9%—
Return on assets-18.3%-18.0%-22.1%-24.8%-18.7%-16.4%—
Revenue growth133.9%-42.6%-27.1%-9.8%-15.7%1856.1%—
Earnings growth1.1%83.7%-18.7%19.0%-0.8%-28.3%—
Current ratio2.06x5.51x1.06x5.51x5.60x8.83x—
Debt to equity0.19x0.30x1.11x0.98x0.47x0.37x—
Equity ratio55.6%66.1%35.4%45.7%59.5%65.9%—
Interest coverage—-11.47x-6.78x-20.05x-18.36x-25.11x-249.06x
R&D as a share of sales101.0%191.8%48.3%86.0%67.2%54.9%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-0.7%-5.7%—
Net income14.7%12.2%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Price to earnings-10.3-15.3-47.5-5.2-14.9-19.6-10.1
Price to sales41.9143.9139.713.829.933.4469.8

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 6-for-5 split · 17 Oct 2024
  • 1967-for-1811 split · 14 Aug 2024

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.